STZ
54
-3
GE
67
2
AN
58
4
TROW
56
5
A
43
2
CMA
61
5
M
37
12
APD
59
2
VNO
60
10
LB
63
22
F
58
11
SCHW
62
-2
ORCL
65
-2
IR
66
3
CPB
30
6
HCA
44
-2
PAYX
53
2
LNC
39
3
EXC
53
-3
NVDA
56
-4
STZ
54
-3
GE
67
2
AN
58
4
TROW
56
5
A
43
2
CMA
61
5
M
37
12
APD
59
2
VNO
60
10
LB
63
22
F
58
11
SCHW
62
-2
ORCL
65
-2
IR
66
3
CPB
30
6
HCA
44
-2
PAYX
53
2
LNC
39
3
EXC
53
-3
NVDA
56
-4
Financhill
Back

Catalyst Pharmaceuticals 10K Form

Sell
48

CPRX
Catalyst Pharmaceuticals

Last Price:
21.47
Seasonality Move:
4.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $398.2M
Cash Flow: $72.61M
Price / Cash Flow: 11.8
Annual Sales: $5.54
Price / Book: 3.88

Profitability

EPS (TTM): 1.18000
Net Income (TTM): $142.8M
Gross Margin: $346.24M
Return on Equity: 27.81%
Return on Assets: 23.73%

Catalyst Pharmaceuticals Earnings Forecast

Key Catalyst Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 22 years for CPRX is 86.95%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 33.58% of Gross Profit Margin.
  • The Research & Development expenses have been 23.39% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

Catalyst Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.11
Quick Ratio: 4.75

Price-to-Earnings

Trailing P/E Ratio: 34.1
Forward P/E Ratio: 10.26

CPRX Technical Analysis vs Fundamental Analysis

Sell
48
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy or a Sell?